ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2025
Virtual arthroplasty follow-up (VARF) in total hip replacement: a safe, effective, and sustainable model for post-operative care.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeVirtual follow-up programmes offer an alternative to traditional in-person appointments, aiming to reduce patient burden and optimise healthcare resources. Following a successful pilot in 2020, the virtual arthroplasty follow-up (VARF) pathway was formally implemented to monitor total hip replacement (THR) patients. This study evaluates the clinical outcomes, patient satisfaction, economic impact, and environmental benefits of VARF in a large cohort.
methodsA retrospective analysis was performed on a prospectively maintained database of 319 patients who underwent primary THR between January 2022 and July 2023. Follow-up was conducted using Oxford Hip Scores (OHS) and radiographs. Patient satisfaction was assessed via telephone survey in a representative sample of 35 patients. Estimated carbon dioxide emissions related to clinic visits were calculated based on previously published data.
resultsA total of 92.2% (n = 294) of patients were successfully managed through VARF. Patient satisfaction was high, with 86% of respondents reporting they were 'satisfied' or 'very satisfied', and 69% perceiving time and cost-savings. Financial analysis demonstrated an average saving of £11.78 per patient in fuel and parking costs. A theoretical cost reduction of £48,978.91 was identified for the Trust, primarily due to operational efficiencies and the release of clinic time. While not a direct monetary saving, this freed capacity allowed reallocation for other clinical purposes, enhancing overall service efficiency. Environmentally, the programme prevented an estimated 19,691 kg of CO
conclusionVARF is a safe, effective, and patient-centred approach for THR follow-up, achieving high satisfaction rates while delivering significant cost and environmental benefits. This model demonstrates strong potential for wider adoption in arthroplasty post-operative care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.